Health Equity is Earned and Learned!

 

In today’s rapidly evolving healthcare landscape, “health equity is earned and learned” captures a vital truth. This critical concept underscores the need for a proactive and educated approach to bridge healthcare outcomes and access disparities.

On the Healthcare Rethink podcast, host Brian Urban welcomes Bonzo Reddick, MD, MPH, FAAFP, a prominent Public Health Leader and Author of “Health Equity, A Guide for Clinicians, Medical Educators & Healthcare Organizations,” to discuss the transformative steps necessary to advance health equity. Dr. Reddick shares insights from his extensive experience and recent publications, offering valuable guidance for medical and educational professionals.

Urban and Reddick’s conversation includes the following:

  • The Importance of Education: Understanding and promoting health equity begins with comprehensive education and awareness at all levels of medical and public health training
  • Integration of Public Health Perspectives: Integrating public health perspectives into everyday medical practices can prevent disparities and enhance healthcare outcomes for underserved communities
  • Practical Strategies for Organizations: Actionable strategies for healthcare organizations to implement that foster equity, including policy adjustments and community engagement initiatives

Dr. Reddick, a professor at Mercer University and the Chief Medical Officer at the Georgia Coastal Health District, utilizes his platform to advocate for systemic changes that support health equity. His journey from Savannah to a leading health professional showcases his commitment to enhancing public health across diverse populations.

 

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More